IDEAS home Printed from https://ideas.repec.org/a/adp/jgjpps/v2y2017i4p92-98.html
   My bibliography  Save this article

A Review of Dalvance for the Treatment of Acute Bacterial Skin and Skin Structure Infections (Absssis)

Author

Listed:
  • Sanyaolu A
  • Abioye A
  • Alaofin B
  • Johnson G
  • Alhussaini A

    (Nigeria Center for Disease Control, Federal Ministry of Health, Nigeria
    Department of Pharmacy, Leicester School of Pharmacy, United Kingdom
    Saint James School of Medicine Anguilla, BWI)

Abstract

Gram positive bacteria can cause resistant to the antibiotics which are currently available for treating acute bacterial skin and skin structure infections (ABSSSIs) thereby rendering the antibiotics unsafe to use for treatment. The production of new drugs for the treatment of this infection as well as other infections caused by the resistant gram positive organisms is imperative for public health. MRSA is a resistant pathogen of special importance in the clinical setting as it is difficult to treat and easy to spread both in the healthcare settings as well as in the community. The newest antibiotic, Dalvance, is promising. It is as effective as other drug protocols like the combination of vancomycin and linezolid. So far, no resistance has been produced against the drug with over ten years in clinical trials. This review discusses the drug description, indications and usage, side effects, drug interactions and non-clinical toxicology, clinical pharmacology, mechanism of action, pharmacodynamics, pharmacokinetics, microbial efficacy, studies, dosage and administration information, of the new drug Dalvance and its importance in the health care system for the treatment of ABSSSIs.

Suggested Citation

  • Sanyaolu A & Abioye A & Alaofin B & Johnson G & Alhussaini A, 2017. "A Review of Dalvance for the Treatment of Acute Bacterial Skin and Skin Structure Infections (Absssis)," Global Journal of Pharmacy & Pharmaceutical Sciences, Juniper Publishers Inc., vol. 2(4), pages 92-98, June.
    • Handle: RePEc:adp:jgjpps:v:2:y:2017:i:4:p:92-98
    DOI: 10.19080/GJPPS.2017.02.555595
    as

    Download full text from publisher

    File URL: https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555595.pdf
    Download Restriction: no
    File URL: https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555595.php
    Download Restriction: no
    File URL: https://libkey.io/10.19080/GJPPS.2017.02.555595?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adp:jgjpps:v:2:y:2017:i:4:p:92-98. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Robert Thomas (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.